A category-sovereign .com domain at the intersection of gene editing, CRISPR therapeutics, synthetic biology, and biotech — available now for qualified buyers.
Complete the form below for a confidential, no-obligation discussion about acquiring GeneDriveLabs.com. All inquiries are treated with complete discretion.
All inquiries are 100% confidential. We respond within 48 business hours. An NDA can be executed prior to any price discussion.
All transactions are processed through Escrow.com — the industry standard for domain acquisitions. Funds are held securely until transfer is verified and complete.
Once payment clears escrow, domain transfer is initiated immediately. Most registrar-to-registrar transfers complete within 24–72 hours depending on your preferred registrar.
GeneDriveLabs.com has a clean chain of title, no trademark disputes, and no encumbrances. Full ownership history and WHOIS documentation available to verified buyers.
We understand that domain acquisitions are often commercially sensitive. Mutual NDAs are available, and all communications are treated with complete discretion.
We prefer outright acquisition, but lease-to-own and licensing arrangements can be discussed for institutional acquirers with the right use case. Contact us to explore options.
Wire transfer, ACH, and major cryptocurrencies (BTC, ETH, USDC) are all accepted through Escrow.com. Credit card payments are available for lower-value transactions.
Yes — GeneDriveLabs.com is listed on Sedo, Afternic, and Dan.com. You may initiate a purchase through any of these platforms if preferred.
The existing website and all editorial content can be included in the acquisition at the buyer's request. This provides immediate SEO equity and a content foundation for the incoming team.
Domain registration history and full provenance documentation will be shared with qualified buyers under NDA prior to price negotiation.